![HeartBEATS from Lifelong Learning™ artwork](https://is3-ssl.mzstatic.com/image/thumb/Podcasts126/v4/d6/26/0e/d6260eb6-6bbe-c851-bd3a-1907f9b2960c/mza_9855028879710213755.jpg/100x100bb.jpg)
Obesity and GLP-1 RAs
HeartBEATS from Lifelong Learning™
English - January 26, 2024 17:17 - 26 minutes - 72.8 MB VideoMedicine Health & Fitness Education Courses sleephealth aha americanheartassociation insomnia sleep sleepapnea Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Chronic Kidney Disease and GLP-1 RAs
Next Episode: Practical Pointers to Optimize the Use of GLP-1 RAs
Conversation about the global rise of obesity and its association with diabetes and the limited effectiveness of many pharmacotherapies tested for management of obesity. You will also learn about weight loss benefits, improvement in cardiovascular risk factors, and potential for cardiovascular event reduction with GLP-1RA therapy in patients with obesity.
Claim CE Credit at https://bit.ly/3OkYJm9